Iterum Therapeutics Plc
XNAS:ITRM 10:34:36 AM EDT
| Market Cap (Intraday) | 19.06M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.34 |
| 50-Day MA | $0.47 |
| 200-Day MA | $0.80 |
Iterum Therapeutics Plc Stock, XNAS:ITRM
3 Dublin Landings, North Wall Quay, Dublin, Dublin 1
Ireland
Phone: +353.1.6694820
Number of Employees: 9
Description
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.